These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 7886572)

  • 1. Plasmapheresis for the preparation of HIV free cryoprecipitate.
    Tardtong P; Chuansumrit A; Stabanswadigan S; Chiewsilp P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():195-7. PubMed ID: 7886572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and plasma derivatives in therapeutic plasmapheresis.
    McLeod BC
    Transfusion; 2012 May; 52 Suppl 1():38S-44S. PubMed ID: 22578370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safe blood components for a hemophilia patient: a case report.
    Chuansumrit A; Pandhawong S; Tardtong P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():198-200. PubMed ID: 7886573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange donation of cryoprecipitate after DDAVP stimulation: an alternative source of factor VIII.
    McLeod BC; Scott JP
    Prog Clin Biol Res; 1990; 324():189-98. PubMed ID: 2106687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unconventional diagnosis of Normandy-type von Willebrand's disease in a blood donor.
    Kashyap S; Nesbitt IM; Makris M
    Transfus Med; 2004 Apr; 14(2):181-4. PubMed ID: 15113383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII, factor IX and fibrinogen content in cryoprecipitate, fresh plasma and cryoprecipitate-removed plasma.
    Bejrachandra S; Chandanayingyong D; Visudhiphan S; Tumliang S; Kaewkamol K; Siribunrit U
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():162-4. PubMed ID: 7886562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
    Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
    Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemostasis with cryoprecipitate in patients undergoing surgery for severe von Willebrand disease.
    Mathews V; Srivastava A; Nair SC; Chandy M
    Natl Med J India; 2000; 13(4):188-90. PubMed ID: 11002685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
    Ching YN; Meyers KM; Brassard JA; Wardrop KJ
    Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
    Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
    Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV seroconversion in Thai hemophiliacs up to 1991.
    Isarangkura P; Chuansumrit A; Hathirat P; Panthangkura W; Mahaphan W; Limsuwan A; Chiewsilp P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():191-4. PubMed ID: 7886571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the blood donation necessary for self-sufficiency of blood products].
    Pinto V; Hernández Mejía R; Cueto A
    Sangre (Barc); 1999 Feb; 44(1):38-43. PubMed ID: 10323095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC.
    Yazer MH; Triulzi DJ; Hassett AC; Kiss JE
    Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus transmission through quarantine fresh-frozen plasma.
    Humpe A; Legler TJ; Nübling CM; Riggert J; Unger G; Wolf C; Heermann KH; Köhler M
    Thromb Haemost; 2000 Nov; 84(5):784-8. PubMed ID: 11127856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.